Literature DB >> 11228406

Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome.

B J Van den Eynde1, S Morel.   

Abstract

Upon exposure to IFN-gamma, the standard proteasome is replaced by the immunoproteasome, which contains LMP2, LMP7 and MECL1, and is considered more efficient at producing antigenic peptides presented to CD8(+) T cells. This view has been challenged this year by reports showing that some epitopes, mainly of self origin, are not processed by the immunoproteasome and that mature dendritic cells constitutively express immunoproteasomes and therefore cannot efficiently present such epitopes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11228406     DOI: 10.1016/s0952-7915(00)00197-7

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  51 in total

1.  Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome.

Authors:  Can Kesmir; Vera van Noort; Rob J de Boer; Paulien Hogeweg
Journal:  Immunogenetics       Date:  2003-08-30       Impact factor: 2.846

2.  Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules.

Authors:  Benoît Guillaume; Jacques Chapiro; Vincent Stroobant; Didier Colau; Benoît Van Holle; Grégory Parvizi; Marie-Pierre Bousquet-Dubouch; Ivan Théate; Nicolas Parmentier; Benoît J Van den Eynde
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

3.  Activity dependent localization of synaptic NMDA receptors in spinal neurons.

Authors:  Kenneth M Rosen; Abhay Moghekar; Richard J O'Brien
Journal:  Mol Cell Neurosci       Date:  2006-12-29       Impact factor: 4.314

4.  Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance.

Authors:  Stefan Tenzer; Edmund Wee; Anne Burgevin; Guillaume Stewart-Jones; Lone Friis; Kasper Lamberth; Chih-hao Chang; Mikkel Harndahl; Mirjana Weimershaus; Jan Gerstoft; Nadja Akkad; Paul Klenerman; Lars Fugger; E Yvonne Jones; Andrew J McMichael; Søren Buus; Hansjörg Schild; Peter van Endert; Astrid K N Iversen
Journal:  Nat Immunol       Date:  2009-05-03       Impact factor: 25.606

Review 5.  Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands.

Authors:  Gabor Mester; Vanessa Hoffmann; Stefan Stevanović
Journal:  Cell Mol Life Sci       Date:  2011-03-09       Impact factor: 9.261

6.  Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.

Authors:  Karina Yusim; Can Kesmir; Brian Gaschen; Marylyn M Addo; Marcus Altfeld; Søren Brunak; Alexandre Chigaev; Vincent Detours; Bette T Korber
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Influenza virus and poly(I:C) inhibit MHC class I-restricted presentation of cell-associated antigens derived from infected dead cells captured by human dendritic cells.

Authors:  Davor Frleta; Chun I Yu; Eynav Klechevsky; Anne-Laure Flamar; Gerard Zurawski; Jacques Banchereau; A Karolina Palucka
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes.

Authors:  Gudrun Szalay; Silke Meiners; Antje Voigt; Jörg Lauber; Christian Spieth; Nora Speer; Martina Sauter; Ulrike Kuckelkorn; Andreas Zell; Karin Klingel; Karl Stangl; Reinhard Kandolf
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

9.  Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus.

Authors:  Michael D Robek; Mayra L Garcia; Bryan S Boyd; Francis V Chisari
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1.

Authors:  Christopher E Touloukian; Wolfgang W Leitner; Rhonda E Schnur; Paul F Robbins; Yong Li; Scott Southwood; Alessandro Sette; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.